News
-
-
-
-
PRESS RELEASE
Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
Bausch Health and Salix Pharmaceuticals provide updates on litigation with Norwich Pharmaceuticals and potential generic version of XIFAXAN. Bausch Health to enforce intellectual property rights. Details on FDA approval process and patent infringement lawsuit -
-
PRESS RELEASE
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
Bausch Health and Salix Pharmaceuticals announce Bellamy Young as Xifaxan brand ambassador to raise awareness on OHE recurrence risk reduction. Campaign aims to educate about complications of cirrhosis -
-
PRESS RELEASE
Bausch Health Announces First Quarter 2024 Results
Bausch Health Companies Inc. reports first quarter 2024 financial results with 11% revenue growth and continued year-over-year revenue increase in all segments. CEO Thomas J. Appio highlights focus on R&D pipeline, balance sheet strength, and global growth strategies -
-
![Accesswire](/assets/images/accesswire-inline.png)
-
Eagle Plains Announces Conditional Approval of Warrant Expiry Extension
-
Goldflare Announces Changes in Leadership
-
Gina Corena & Associates Participates in 2024 Nevada Justice Association Annual Summer Gala This Weekend
-
Canada Jetlines Announces Loan
-
Pixalate Introduces EMEA Connected TV (CTV) Supply-Side Platform (SSP) Market Share Rankings: Magnite No. 1 With 43% Market Share in Q1 2024
![EQS Group](/assets/images/eqs-group.png)
-
EQS-Adhoc: VOLKSWAGEN AKTIENGESELLSCHAFT: Volkswagen AG resolves on investment by Volkswagen of initially 1 billion USD in Rivian Automotive, Inc., and intends to establish a joint venture
-
CompuGroup Medical strengthens market position in Northern Europe with the acquisition of Norwegian Pridok
-
EQS-Adhoc: CompuGroup Medical SE & Co. KGaA: CompuGroup Medical acquires Pridok AS
-
Molten Ventures Plc: HOL-Holding(s) in Company
-
Annual General Meeting 2024 of Meyer Burger approves all motions
![Les Echos](/assets/images/les-echos.png)
-
RESULTS OF THE COMBINED GENERAL MEETING ON JUNE 24, 2024
-
Schneider Electric announces the reference share price and the initial conversion/exchange ratio of its new bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2031 and the results of the repurchase of the OCEANEs
-
FREY signs new financing for €400m
-
Schneider Electric announces the success of its offering of bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2031 for a nominal amount of €750 million
-
Cie du Bois Sauvage: Buy back of own shares – week from 17/06/2024 to 21/06/2024